Thea Pharma, Inc. recalls

2 recalls.

• Similasan recall (Thea Pharma, Inc.)
  DrugClass IIReported May 6, 2026 · Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.
• iVIZIA recall (Thea Pharma, Inc.)
  DrugClass IIReported May 6, 2026 · Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.